{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:06:34Z","timestamp":1790165194363,"version":"4.1.0"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.drup.2026.101474","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:56:35Z","timestamp":1789602995000},"page":"101474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Extracellular vesicle-mediated drug resistance in cancer"],"prefix":"10.1016","volume":"90","author":[{"given":"Baiwei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumari","family":"Swati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5929-3176","authenticated-orcid":false,"given":"Kushi","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhel","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.drup.2026.101474_bib1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/13543784.2024.2360209","article-title":"The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy","volume":"33","author":"Aghakhani","year":"2024","journal-title":"Expert. Opin. Investig. Drugs"},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncb1725","article-title":"Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells","volume":"10","author":"Al-Nedawi","year":"2008","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","article-title":"Target c-Myc to treat pancreatic cancer","volume":"23","author":"Ala","year":"2022","journal-title":"Cancer Biol. & Ther."},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1158\/2159-8290.CD-20-1638","article-title":"Overcoming resistance to tumor-targeted and immune-targeted therapies","volume":"11","author":"Aldea","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2026.101474_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","article-title":"Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Cancer Cell. Int."},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes. & Dis."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2019","journal-title":"Medicina"},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11060-013-1235-y","article-title":"Heparin blocks transfer of extracellular vesicles between donor and recipient cells","volume":"115","author":"Atai","year":"2013","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib9","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1038\/ncomms8439","article-title":"A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure","volume":"6","author":"Atkin-Smith","year":"2015","journal-title":"Nat. Commun."},{"issue":"37","key":"10.1016\/j.drup.2026.101474_bib10","doi-asserted-by":"crossref","first-page":"15336","DOI":"10.1073\/pnas.1102855108","article-title":"Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3","volume":"108","author":"Aung","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.drup.2026.101474_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8839978","article-title":"Clinical implications of exosomal PD-L1 in cancer immunotherapy","volume":"2021","author":"Ayala-Mar","year":"2021","journal-title":"J. Immunol. Res."},{"issue":"7120","key":"10.1016\/j.drup.2026.101474_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib13","article-title":"AML-derived extracellular vesicles confer de novo chemoresistance to leukemic myeloblast cells by promoting drug export genes expression and ROS inhibition","volume":"20","author":"Barzegar","year":"2021","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.drup.2026.101474_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1152\/physrev.00019.2024","article-title":"The influence of extracellular vesicles on tumor evolution and resistance to therapy","volume":"105","author":"Bast\u00f3n","year":"2025","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.drup.2026.101474_bib16","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/leu.2009.76","article-title":"Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells","volume":"23","author":"Bebawy","year":"2009","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189275","article-title":"Extracellular vesicles and the tumour microenvironment","volume":"1880","author":"Bel\u00e9nyesi","year":"2025","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews Cancer"},{"issue":"12","key":"10.1016\/j.drup.2026.101474_bib18","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/cells9122598","article-title":"Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance","volume":"9","author":"Belisario","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.drup.2026.101474_bib19","article-title":"Extracellular vesicles in the chronic myeloid leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules","volume":"13","author":"Bernardi","year":"2023","journal-title":"Front. Oncol."},{"issue":"18","key":"10.1016\/j.drup.2026.101474_bib20","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-18-0124","article-title":"Transfer of miRNA in macrophage-derived exosomes induces drug resistance in pancreatic adenocarcinoma","volume":"78","author":"Binenbaum","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13046-019-1517-0","article-title":"Targeting hypoxia in tumor: a new promising therapeutic strategy","volume":"39","author":"Bosco","year":"2020","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101474_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.leukres.2017.09.014","article-title":"Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo","volume":"62","author":"Bouvy","year":"2017","journal-title":"Leuk. Res."},{"issue":"38","key":"10.1016\/j.drup.2026.101474_bib23","doi-asserted-by":"crossref","first-page":"53110","DOI":"10.1021\/acsami.5c09959","article-title":"RNA sequencing at single vesicle resolution via 3D printed embedded droplet arrays","volume":"17","author":"Brock","year":"2025","journal-title":"ACS Appl. Mater. & Interfaces"},{"issue":"12","key":"10.1016\/j.drup.2026.101474_bib24","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3390\/cancers16122259","article-title":"Resistance to targeted inhibitors of the PI3K\/AKT\/mTOR pathway in advanced oestrogen-receptor-positive breast cancer","volume":"16","author":"Browne","year":"2024","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.drup.2026.101474_bib25","first-page":"1633","article-title":"Extracellular vesicles and cancer multidrug resistance: undesirable intercellular messengers?","volume":"13","author":"Bucci-Mu\u00f1oz","year":"2023","journal-title":"Life (Basel Switz. )"},{"issue":"13","key":"10.1016\/j.drup.2026.101474_bib26","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.3390\/cancers13133324","article-title":"Extracellular vesicles as mediators of cancer disease and as nanosystems in theranostic applications","volume":"13","author":"Burgos-Ravanal","year":"2021","journal-title":"Cancers"},{"issue":"51","key":"10.1016\/j.drup.2026.101474_bib27","doi-asserted-by":"crossref","first-page":"84453","DOI":"10.18632\/oncotarget.11497","article-title":"EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells","volume":"7","author":"Cardenas","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.drup.2026.101474_bib28","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2174\/0929867325666180105103637","article-title":"ABC transporters: regulation and association with multidrug resistance in hepatocellular carcinoma and colorectal carcinoma","volume":"26","author":"Ceballos","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.drup.2026.101474_bib29","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1074\/jbc.RA117.000634","article-title":"X-linked inhibitor of apoptosis protein (XIAP) is a client of heat shock protein 70 (Hsp70) and a biomarker of its inhibition","volume":"293","author":"Cesa","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-018-0886-x","article-title":"A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells","volume":"17","author":"Cesi","year":"2018","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.drup.2026.101474_bib31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2008.103","article-title":"Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration","volume":"22","author":"Chapuy","year":"2008","journal-title":"Leukemia"},{"issue":"7718","key":"10.1016\/j.drup.2026.101474_bib32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"36","key":"10.1016\/j.drup.2026.101474_bib33","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.2174\/0113816128361848250401200001","article-title":"The role of MicroRNAs, CircRNAs, and LncRNAs in chronic lymphocytic leukemia","volume":"31","author":"Chen","year":"2025","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib34","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.18632\/oncotarget.12461","article-title":"Long non-coding RNAs in anti-cancer drug resistance","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2026.101474_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lfs.2019.02.003","article-title":"Leukemia-derived exosomes induced IL-8 production in bone marrow stromal cells to protect the leukemia cells against chemotherapy","volume":"221","author":"Chen","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1740936","article-title":"Cancer stem cell quiescence and plasticity as major challenges in cancer therapy","volume":"2016","author":"Chen","year":"2016","journal-title":"Stem Cells Int."},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095240","article-title":"Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of MicroRNAs","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS. ONE"},{"issue":"11","key":"10.1016\/j.drup.2026.101474_bib38","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","article-title":"Mutant p53 in cancer: from molecular mechanism to therapeutic modulation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell. Death & Dis."},{"issue":"7","key":"10.1016\/j.drup.2026.101474_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2023.12.010","article-title":"Extracellular vesicles in anti-tumor drug resistance: mechanisms and therapeutic prospects","volume":"14","author":"Cheng","year":"2024","journal-title":"J. Pharm. Anal."},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3892\/mmr.2016.6078","article-title":"Role of miR-223\/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells","volume":"15","author":"Cheng","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12929-020-0627-5","article-title":"Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE","volume":"27","author":"Cheung","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.drup.2026.101474_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.671082","article-title":"Exosomal lncRNA UCA1 derived from pancreatic stellate cells promotes gemcitabine resistance in pancreatic cancer via the SOCS3\/EZH2 axis","volume":"11","author":"Chi","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib43","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcp.22773","article-title":"Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy","volume":"227","author":"Ciravolo","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.drup.2026.101474_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103112","article-title":"International liquid biopsy standardization alliance white paper","volume":"156","author":"Connors","year":"2020","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"12","key":"10.1016\/j.drup.2026.101474_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050999","article-title":"Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes","volume":"7","author":"Corcoran","year":"2012","journal-title":"PLoS. ONE"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1710899","article-title":"Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients","volume":"9","author":"Cordonnier","year":"2020","journal-title":"J. Extracell. Vesicles"},{"issue":"12","key":"10.1016\/j.drup.2026.101474_bib47","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.3390\/cells10123355","article-title":"Molecular mediators of RNA loading into extracellular vesicles","volume":"10","author":"Corrado","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.drup.2026.101474_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cncr.34576","article-title":"Baseline extracellular vesicle TGF-\u03b2 is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer","volume":"129","author":"de Miguel-Perez","year":"2023","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.drup.2026.101474_bib50","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/annonc\/mdh388","article-title":"Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase\/Akt pathway","volume":"15","author":"deGraffenried","year":"2004","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.drup.2026.101474_bib51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/bjc.2018.9","article-title":"PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC","volume":"118","author":"Del Re","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.40","article-title":"Unpacking extracellular vesicles: RNA cargo loading and function","volume":"1","author":"Dellar","year":"2022","journal-title":"J. Extracell. Biol."},{"key":"10.1016\/j.drup.2026.101474_bib53","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2147\/OTT.S186922","article-title":"Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin","volume":"12","author":"Dong","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib54","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41375-018-0254-2","article-title":"Transmissible ER stress reconfigures the AML bone marrow compartment","volume":"33","author":"Doron","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2026.101474_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114643","article-title":"Overcoming cancer multi-drug resistance (MDR): reasons, mechanisms, nanotherapeutic solutions, and challenges","volume":"162","author":"Duan","year":"2023","journal-title":"Biomed. & Pharmacother."},{"issue":"23","key":"10.1016\/j.drup.2026.101474_bib56","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.3390\/ijms21239248","article-title":"Role of nucleotide excision repair in cisplatin resistance","volume":"21","author":"Duan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101474_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891652","article-title":"Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches","volume":"12","author":"Emran","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2026.101474_bib58","doi-asserted-by":"crossref","unstructured":"EZH2 and cancer progression: An intricate relation that continues to grow. (2021). Journal of Breast Cancer Research, 1(1). https:\/\/doi.org\/10.46439\/breastcancer.1.003.","DOI":"10.46439\/breastcancer.1.003"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088193","article-title":"Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin","volume":"9","author":"Federici","year":"2014","journal-title":"PLoS. ONE"},{"key":"10.1016\/j.drup.2026.101474_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1467602","article-title":"Targeting extracellular matrix stiffness for cancer therapy","volume":"15","author":"Feng","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib61","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/cancers13040749","article-title":"Extracellular vesicles: emerging modulators of cancer drug resistance","volume":"13","author":"Fontana","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib62","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","article-title":"Survivin: a unique target for tumor therapy","volume":"16","author":"Garg","year":"2016","journal-title":"Cancer Cell. Int."},{"issue":"10","key":"10.1016\/j.drup.2026.101474_bib64","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41571-025-01059-1","article-title":"Understanding and overcoming multidrug resistance in cancer","volume":"22","author":"Ge","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.drup.2026.101474_bib65","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41419-022-05056-5","article-title":"Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p\/MGMT axis in glioma","volume":"13","author":"Geng","year":"2022","journal-title":"Cell. Death & Dis."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","article-title":"The clinical role of the TME in solid cancer","volume":"120","author":"Giraldo","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2026.101474_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103404","article-title":"Targeting catalase in cancer","volume":"77","author":"Glorieux","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.drup.2026.101474_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00120","article-title":"Targeting nuclear factor-kappa B to overcome resistance to chemotherapy","volume":"3","author":"Godwin","year":"2013","journal-title":"Front. Oncol."},{"issue":"14","key":"10.1016\/j.drup.2026.101474_bib69","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM200104053441409","article-title":"Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Goldman","year":"2001","journal-title":"New. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib70","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43556-024-00239-2","article-title":"Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer","volume":"6","author":"Gu","year":"2025","journal-title":"Mol. Biomed."},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ddc4020015","article-title":"Epigenetic alterations in cancer: the therapeutic potential of epigenetic drugs in cancer therapy","volume":"4","author":"Gupta","year":"2025","journal-title":"Drugs Drug. Candidates"},{"key":"10.1016\/j.drup.2026.101474_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216960","article-title":"Revisiting the advances and challenges in the clinical applications of extracellular vesicles in cancer","volume":"593","author":"He","year":"2024","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.drup.2026.101474_bib73","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"New. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.drup.2026.101474_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12828","article-title":"Role of exosomal microRNAs in lung cancer biology and clinical applications","volume":"53","author":"Hu","year":"2020","journal-title":"Cell. Prolif."},{"issue":"8","key":"10.1016\/j.drup.2026.101474_bib75","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3390\/pharmaceutics14081606","article-title":"Nanomedicines for overcoming cancer drug resistance","volume":"14","author":"Hu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drup.2026.101474_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.148750","article-title":"Exosomal microRNA-20b-5p contributes to cytarabine resistance in acute myeloid leukemia via the microtubule-associated serine\/threonine kinase-like\u2013phosphatidylinositol 3-kinase\u2013protein kinase B signaling axis","volume":"333","author":"Huang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib77","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","article-title":"The role of tumor-associated macrophages in tumor immune evasion","volume":"150","author":"Huang","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.drup.2026.101474_bib78","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1158\/0008-5472.CAN-05-2021","article-title":"Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance","volume":"65","author":"Ifergan","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib79","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"J","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061515","article-title":"Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells","volume":"8","author":"Jaiswal","year":"2013","journal-title":"PLoS. ONE"},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib81","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.ymthe.2025.02.020","article-title":"Addressing barriers to clinical translation of extracellular vesicle therapeutics","volume":"33","author":"Jay","year":"2025","journal-title":"Mol. Ther."},{"issue":"15","key":"10.1016\/j.drup.2026.101474_bib82","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1080\/15384101.2015.1005530","article-title":"Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer","volume":"14","author":"Ji","year":"2015","journal-title":"Cell Cycle (Georgetown Tex. )"},{"issue":"6","key":"10.1016\/j.drup.2026.101474_bib83","article-title":"Molecular mechanisms of cisplatin resistance in ovarian cancer","volume":"11","author":"Jiang","year":"2024","journal-title":"Genes. & Dis."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib84","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1186\/s12885-025-14375-7","article-title":"Extracellular vesicles in cancer: from isolation and characterization to metastasis, drug resistance, and clinical applications","volume":"25","author":"Jurj","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6478","key":"10.1016\/j.drup.2026.101474_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology , function , and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib87","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/cn100078a","article-title":"The \u201cspecific\u201d P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP\/ABCG2)","volume":"2","author":"Kannan","year":"2011","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.drup.2026.101474_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1603855","article-title":"Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy","volume":"16","author":"Kansha","year":"2025","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.drup.2026.101474_bib89","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.1021\/acsnano.3c12556","article-title":"Single extracellular vesicle imaging and computational analysis identifies inherent architectural heterogeneity","volume":"18","author":"Kapoor","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2026.101474_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105049","article-title":"Survivin expression and impact on head and neck cancer outcomes","volume":"112","author":"Khan","year":"2021","journal-title":"Oral. Oncol."},{"issue":"25","key":"10.1016\/j.drup.2026.101474_bib91","doi-asserted-by":"crossref","first-page":"21740","DOI":"10.18632\/oncotarget.3226","article-title":"Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel","volume":"6","author":"Kharaziha","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib92","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbrc.2016.07.124","article-title":"Exosome cargo reflects TGF-\u03b21-mediated epithelial-to-mesenchymal transition (EMT) status in A549 human lung adenocarcinoma cells","volume":"478","author":"Kim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib93","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s12276-025-01622-x","article-title":"Computational frameworks for enhanced extracellular vesicle biomarker discovery","volume":"58","author":"Kim","year":"2026","journal-title":"Exp. & Mol. Med."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib94","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.drup.2026.101474_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100787","article-title":"Hypoxia as a driver of resistance to immunotherapy","volume":"59","author":"Kopecka","year":"2021","journal-title":"Drug. Resist. Updates"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"23","key":"10.1016\/j.drup.2026.101474_bib97","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1038\/s41388-021-01829-y","article-title":"Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma","volume":"40","author":"Kunou","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101474_bib98","doi-asserted-by":"crossref","DOI":"10.1101\/2025.03.03.25322827","article-title":"KRASG12D -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients","author":"LeBleu","year":"2025","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib99","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.drup.2026.101474_bib100","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3390\/cancers16091729","article-title":"Hypoxia-inducible factor-dependent and independent mechanisms underlying chemoresistance of hypoxic cancer cells","volume":"16","author":"Lee","year":"2024","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.drup.2026.101474_bib101","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1073\/pnas.0401851102","article-title":"Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells","volume":"102","author":"Levchenko","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib102","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12964-025-02340-7","article-title":"MIR4726EccDNA drives bortezomib resistance in multiple myeloma by enhancing MIR4726-5p\/NXF1\/NKIRAS2 axis dependent autophagy","volume":"23","author":"Li","year":"2025","journal-title":"Cell. Commun. Signal."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib103","first-page":"223","article-title":"Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and global burden of disease study","volume":"4","author":"Li","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.drup.2026.101474_bib104","article-title":"Chemoresistance transmission via exosome-transferred MMP14 in pancreatic cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.drup.2026.101474_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.70058","article-title":"Systematic evaluation of isolation techniques and freeze-thaw effects on plasma extracellular vesicle heterogeneity and subpopulation profiling","volume":"4","author":"Li","year":"2025","journal-title":"J. Extracell. Biol."},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib106","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1159\/000485780","article-title":"Exosomal MicroRNA MiR-1246 promotes cell proliferation, invasion and drug resistance by targeting CCNG2 in breast cancer","volume":"44","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41392-019-0080-7","article-title":"The roles of exosomal miRNAs and lncRNAs in lung diseases","volume":"4","author":"Li","year":"2019","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101474_bib108","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211036304","article-title":"Hypoxia and the tumor microenvironment","volume":"20","author":"Li","year":"2021","journal-title":"Technol. Cancer Res. & Treat."},{"key":"10.1016\/j.drup.2026.101474_bib109","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.semcancer.2021.11.004","article-title":"Tumor microenvironment and cellular senescence: understanding therapeutic resistance and harnessing strategies","volume":"86","author":"Liu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"770","key":"10.1016\/j.drup.2026.101474_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado2402","article-title":"Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy","volume":"16","author":"Liu","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12951-023-01801-w","article-title":"Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling","volume":"21","author":"Liu","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib112","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/jcmm.14838","article-title":"Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K\/AKT signalling pathway","volume":"24","author":"Liu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2026.101474_bib113","article-title":"miR\u201121\u20115p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer","author":"Liu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.drup.2026.101474_bib114","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1039\/C9LC01190K","article-title":"Microfluidic device for high-throughput affinity-based isolation of extracellular vesicles","volume":"20","author":"Lo","year":"2020","journal-title":"Lab. a Chip"},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093979","article-title":"Active trafficking of alpha 1 antitrypsin across the lung endothelium","volume":"9","author":"Lockett","year":"2014","journal-title":"PLoS. ONE"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib116","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13346-016-0353-4","article-title":"A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells","volume":"7","author":"Lu","year":"2017","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: The potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101474_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155410","article-title":"Exosomal miR-19a derived from melanoma cell promotes the vemurafenib resistance of malignant melanoma through directly targeting LRIG1 to reactivate AKT and MAPK pathway","volume":"260","author":"Luan","year":"2024","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.drup.2026.101474_bib119","first-page":"1","article-title":"Exosome-mediated transfer of miR-3613-5p enhances doxorubicin resistance by suppression of PTEN expression in breast cancer cells","volume":"2022","author":"Luo","year":"2022","journal-title":"J. Oncol."},{"issue":"11","key":"10.1016\/j.drup.2026.101474_bib120","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1007\/s13277-014-2377-z","article-title":"Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein","volume":"35","author":"Lv","year":"2014","journal-title":"Tumor Biol."},{"issue":"8","key":"10.1016\/j.drup.2026.101474_bib121","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1158\/1078-0432.CCR-16-0453","article-title":"The MAPK pathway regulates intrinsic resistance to BET inhibitors in colorectal cancer","volume":"23","author":"Ma","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101474_bib122","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.2147\/IJN.S221383","article-title":"Exosomal transfer of cisplatin-induced miR-425-3p confers cisplatin resistance In NSCLC through activating autophagy","volume":"14","author":"Ma","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.drup.2026.101474_bib123","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.3390\/ijms22084166","article-title":"The role of extracellular vesicles in mediating resistance to anticancer therapies","volume":"22","author":"Maleki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib124","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s44222-024-00255-5","article-title":"The physico-chemical landscape of extracellular vesicles","volume":"3","author":"Manno","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib127","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell. Biol."},{"issue":"7","key":"10.1016\/j.drup.2026.101474_bib128","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","article-title":"A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy","volume":"2","author":"McKiernan","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.drup.2026.101474_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107522","article-title":"Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights","volume":"210","author":"Meador","year":"2020","journal-title":"Pharmacol. & Ther."},{"issue":"12","key":"10.1016\/j.drup.2026.101474_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70005","article-title":"Extracellular vesicles, RNA sequencing, and bioinformatic analyses: challenges, solutions, and recommendations","volume":"13","author":"Miceli","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib131","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.yexcr.2017.12.001","article-title":"Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365","volume":"362","author":"Min","year":"2018","journal-title":"Exp. Cell. Res."},{"issue":"10","key":"10.1016\/j.drup.2026.101474_bib132","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12510","article-title":"A critical systematic review of extracellular vesicle clinical trials","volume":"13","author":"Mizenko","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12400","article-title":"A beginner\u2019s guide to study extracellular vesicles in human blood plasma and serum","volume":"13","author":"Nieuwland","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.drup.2026.101474_bib134","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3389\/fphar.2019.01500","article-title":"Non-exosomal and exosomal circulatory MicroRNAs: which are more valid as biomarkers?","volume":"10","author":"Nik Mohamed Kamal","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"7605","key":"10.1016\/j.drup.2026.101474_bib135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101474_bib136","article-title":"Drug resistance in glioblastoma: the two faces of oxidative stress","volume":"7","author":"Olivier","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib137","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/cam.20377","article-title":"The role of the myofibroblast in tumor stroma remodeling","volume":"6","author":"Otranto","year":"2012","journal-title":"Cell. Adhes. & Migr."},{"key":"10.1016\/j.drup.2026.101474_bib138","doi-asserted-by":"crossref","DOI":"10.21037\/tgh-23-53","article-title":"Extracellular vesicles in pancreatic cancer: a new era in precision medicine","volume":"9","author":"Panda","year":"2024","journal-title":"Transl. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.drup.2026.101474_bib139","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/ncrna10060054","article-title":"Extracellular vesicle lncRNAs as Key Biomolecules for Cell-to-Cell Communication and Circulating Cancer Biomarkers","volume":"10","author":"Papoutsoglou","year":"2024","journal-title":"Non-Coding RNA"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cpt.2024.04.005","article-title":"Exploring the significance of extracellular vesicles: key players in advancing cancer and possible theranostic tools","volume":"3","author":"Patel","year":"2025","journal-title":"Cancer Pathog. Ther."},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib141","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/bjc.2017.18","article-title":"Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK","volume":"116","author":"Patel","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.drup.2026.101474_bib142","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1097\/MS9.0000000000001061","article-title":"Circulating miR-221\/222 expression as microRNA biomarker predicting tamoxifen treatment outcome: a case-control study","volume":"85","author":"Patellongi","year":"2023","journal-title":"Ann. Med. Surg."},{"issue":"6","key":"10.1016\/j.drup.2026.101474_bib143","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2026.101474_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5416923","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib145","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101474_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.933675","article-title":"Extracellular vesicles and resistance to anticancer drugs: a tumor skeleton key for unhinging chemotherapies","volume":"12","author":"Pompili","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.drup.2026.101474_bib147","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s12276-020-0464-3","article-title":"Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment","volume":"52","author":"Poojan","year":"2020","journal-title":"Exp. & Mol. Med."},{"key":"10.1016\/j.drup.2026.101474_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113872","article-title":"Adherence to minimal experimental requirements for defining extracellular vesicles and their functions","volume":"176","author":"Poupardin","year":"2021","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"6282","key":"10.1016\/j.drup.2026.101474_bib149","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.aaf1328","article-title":"SCS macrophages suppress melanoma by restricting tumor-derived vesicle\u2013B cell interactions","volume":"352","author":"Pucci","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.drup.2026.101474_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib151","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13059-018-1604-0","article-title":"Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5","volume":"20","author":"Qin","year":"2019","journal-title":"Genome Biol."},{"issue":"26","key":"10.1016\/j.drup.2026.101474_bib152","doi-asserted-by":"crossref","first-page":"42125","DOI":"10.18632\/oncotarget.15009","article-title":"Comparative analysis of microRNA expression profiles between A549, A549\/DDP and their respective exosomes","volume":"8","author":"Qin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2026.101474_bib153","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.2147\/IJN.S131516","article-title":"Cisplatin-resistant lung cancer cell\u2013derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100\u20135p-dependent manner","volume":"12","author":"Qin","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib154","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","article-title":"Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA","volume":"29","author":"Qu","year":"2016","journal-title":"Cancer Cell."},{"issue":"11","key":"10.1016\/j.drup.2026.101474_bib155","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.3390\/cancers14112812","article-title":"Cancer-associated fibroblasts confer gemcitabine resistance to pancreatic cancer cells through PTEN-targeting miRNAs in exosomes","volume":"14","author":"Richards","year":"2022","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.drup.2026.101474_bib156","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib157","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell\u2013derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib158","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101474_bib159","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2019.07.017","article-title":"Acquired resistance to cancer immunotherapy: role of tumor-mediated immunosuppression","volume":"65","author":"Saleh","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2026.101474_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1468229","article-title":"Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response","volume":"15","author":"Santos","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib161","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drup.2010.02.001","article-title":"Implication of microRNAs in drug resistance for designing novel cancer therapy","volume":"13","author":"Sarkar","year":"2010","journal-title":"Drug. Resist. Updates"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib162","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1038\/ncomms7999","article-title":"Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma","volume":"6","author":"Shao","year":"2015","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.drup.2026.101474_bib163","first-page":"4331","article-title":"Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles","volume":"63","author":"Shedden","year":"2003","journal-title":"Cancer Res."},{"issue":"162","key":"10.1016\/j.drup.2026.101474_bib164","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2019.0722","article-title":"Mitigating temozolomide resistance in glioblastoma via DNA damage-repair inhibition","volume":"17","author":"Sorribes","year":"2020","journal-title":"J. R. Soc. Interface"},{"issue":"10","key":"10.1016\/j.drup.2026.101474_bib165","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.molmed.2015.08.002","article-title":"Intercellular transfer of cancer drug resistance traits by extracellular vesicles","volume":"21","author":"Sousa","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib166","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-018-1163-y","article-title":"Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial","volume":"16","author":"Stevic","year":"2018","journal-title":"BMC Med."},{"issue":"17","key":"10.1016\/j.drup.2026.101474_bib167","doi-asserted-by":"crossref","first-page":"16193","DOI":"10.1021\/acsnano.5c00705","article-title":"Toward clarity in single extracellular vesicle research: defining the field and correcting missteps","volume":"19","author":"Su","year":"2025","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.drup.2026.101474_bib168","doi-asserted-by":"crossref","DOI":"10.21037\/tcr-20-3426","article-title":"Cinnamophilin enhances temozolomide-induced cytotoxicity against malignant glioma: the roles of ROS and cell cycle arrest","volume":"10","author":"Tai","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib169","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.fob.2014.04.007","article-title":"Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer","volume":"4","author":"Takahashi","year":"2014","journal-title":"FEBS Open. Bio"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12038-019-9861-y","article-title":"Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients","volume":"44","author":"Tang","year":"2019","journal-title":"J. Biosci."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib171","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.drup.2026.101474_bib172","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1200\/JCO.2000.18.9.1837","article-title":"P-glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein\u2013positive acute myeloid leukemia","volume":"18","author":"Tidefelt","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib173","first-page":"577","article-title":"Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance","volume":"5","author":"To","year":"2022","journal-title":"Cancer Drug Resistance (Alhambra Calif. )"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib174","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/ijo.2016.3509","article-title":"Multimodal transfer of MDR by exosomes in human osteosarcoma","volume":"49","author":"Torreggiani","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/ijms18010085","article-title":"Molecular biomarkers for prediction of targeted therapy response in metastatic breast cancer: trick or treat?","volume":"18","author":"Toss","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib176","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/annonc\/mdu049","article-title":"Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition","volume":"25","author":"Turajlic","year":"2014","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib177","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41391-020-0237-z","article-title":"Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10\u2009ng\/ML","volume":"23","author":"Tutrone","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib178","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41391-023-00675-1","article-title":"ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer\u2014an interim analysis","volume":"26","author":"Tutrone","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"16","key":"10.1016\/j.drup.2026.101474_bib179","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1158\/0008-5472.CAN-19-3803","article-title":"Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 Induces FAK-YAP activation by stabilizing \u03b21 integrin, enhancing drug resistance","volume":"80","author":"Uchihara","year":"2020","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.drup.2026.101474_bib180","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12458","article-title":"A systematic review and meta-analysis of clinical trials assessing safety and efficacy of human extracellular vesicle-based therapy","volume":"13","author":"Van Delen","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.drup.2026.101474_bib181","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.omtm.2023.05.009","article-title":"Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value","volume":"29","author":"Vannini","year":"2023","journal-title":"Mol. Ther. - Methods & Clin. Dev."},{"issue":"11","key":"10.1016\/j.drup.2026.101474_bib182","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.neo.2017.07.002","article-title":"Intercellular resistance to BRAF inhibition can be mediated by extracellular vesicle\u2013associated PDGFR\u03b2","volume":"19","author":"Vella","year":"2017","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.drup.2026.101474_bib183","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/bjh.13551","article-title":"Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance","volume":"172","author":"Viola","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib184","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41698-024-00526-9","article-title":"Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy","volume":"8","author":"Walmsley","year":"2024","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.drup.2026.101474_bib185","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2147\/OTT.S428707","article-title":"GW4869 can inhibit epithelial-mesenchymal transition and extracellular HSP90\u03b1 in gefitinib-sensitive NSCLC cells","volume":"16","author":"Wan","year":"2023","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.drup.2026.101474_bib186","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.2147\/OTT.S231846","article-title":"Exosome-mediated transfer of lncRNA HOTTIP promotes cisplatin resistance in gastric cancer cells by regulating HMGA1\/miR-218 axis","volume":"12","author":"Wang","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"10","key":"10.1016\/j.drup.2026.101474_bib187","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1002\/jcp.29585","article-title":"Exosome-mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer","volume":"235","author":"Wang","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.drup.2026.101474_bib188","first-page":"1337","article-title":"Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery system","volume":"7","author":"Wang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.drup.2026.101474_bib189","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2019.10","article-title":"Drug resistance and combating drug resistance in cancer","author":"Wang","year":"2019","journal-title":"Cancer Drug. Resist."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib190","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/cei\/uxac045","article-title":"Exosomal PD-L1 predicts response with immunotherapy in NSCLC patients","volume":"208","author":"Wang","year":"2022","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib191","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-017-0694-8","article-title":"Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p","volume":"16","author":"Wei","year":"2017","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib192","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10549-014-3037-0","article-title":"Exosomal miR-221\/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells","volume":"147","author":"Wei","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"issue":"D1","key":"10.1016\/j.drup.2026.101474_bib193","doi-asserted-by":"crossref","first-page":"D1807","DOI":"10.1093\/nar\/gkaf1189","article-title":"SVAtlas: a comprehensive single extracellular vesicle omics resource","volume":"54","author":"Wei","year":"2026","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.drup.2026.101474_bib194","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib195","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1152\/physrev.00024.2015","article-title":"Acquired resistance to clinical cancer therapy: a twist in physiological signaling","volume":"96","author":"Wicki","year":"2016","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.drup.2026.101474_bib196","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/jcmm.13056","article-title":"Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7","volume":"21","author":"Wu","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib197","article-title":"Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2026.101474_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100833","article-title":"The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells","volume":"62","author":"Xavier","year":"2022","journal-title":"Drug. Resist. Updates"},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib199","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/cells9051141","article-title":"The role of extracellular vesicles in the hallmarks of cancer and drug resistance","volume":"9","author":"Xavier","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.drup.2026.101474_bib200","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.gendis.2022.03.021","article-title":"The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): intercellular shuttles and implications in human diseases","volume":"10","author":"Xu","year":"2023","journal-title":"Genes. & Dis."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib201","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.drup.2026.101474_bib202","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2024.84","article-title":"Intercellular transfer of multidrug resistance mediated by extracellular vesicles","author":"Yang","year":"2024","journal-title":"Cancer Drug. Resist."},{"issue":"34","key":"10.1016\/j.drup.2026.101474_bib203","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201609","article-title":"Extracellular vesicles in cancer drug resistance: roles, mechanisms, and implications","volume":"9","author":"Yang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2026.101474_bib204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","article-title":"The roles of microRNAs in epigenetic regulation","volume":"51","author":"Yao","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"8","key":"10.1016\/j.drup.2026.101474_bib205","article-title":"Machine learning-based analysis identifies and validates serum exosomal proteomic signatures for the diagnosis of colorectal cancer","volume":"5","author":"Yin","year":"2024","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.drup.2026.101474_bib206","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ebiom.2019.03.016","article-title":"Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma","volume":"42","author":"Yin","year":"2019","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib207","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00262-022-03305-2","article-title":"Extracellular vesicles derived from M2-polarized tumor-associated macrophages promote immune escape in ovarian cancer through NEAT1\/miR-101-3p\/ZEB1\/PD-L1 axis","volume":"72","author":"Yin","year":"2023","journal-title":"Cancer Immunology Immunotherapy CII"},{"key":"10.1016\/j.drup.2026.101474_bib208","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.canlet.2018.06.041","article-title":"Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype","volume":"433","author":"Yu","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib209","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41392-020-0182-2","article-title":"miR-410 induces both epithelial\u2013mesenchymal transition and radioresistance through activation of the PI3K\/mTOR pathway in non-small cell lung cancer","volume":"5","author":"Yuan","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101474_bib210","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.816698","article-title":"Biological features of extracellular vesicles and challenges","volume":"10","author":"Zeng","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"issue":"36","key":"10.1016\/j.drup.2026.101474_bib211","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1038\/s41388-021-01960-w","article-title":"Hypoxic exosomal HIF-1\u03b1-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis","volume":"40","author":"Zeng","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101474_bib212","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2014.05.026","article-title":"Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance","volume":"738","author":"Zhang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib213","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","article-title":"CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101474_bib214","article-title":"Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib215","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acssensors.3c02789","article-title":"Deep learning promotes profiling of multiple miRNAs in single extracellular vesicles for cancer diagnosis","volume":"9","author":"Zhang","year":"2024","journal-title":"ACS Sens."},{"issue":"1\u20134","key":"10.1016\/j.drup.2026.101474_bib216","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbrc.2018.11.061","article-title":"Exosomal transfer of miR-214 mediates gefitinib resistance in non-small cell lung cancer","volume":"507","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib217","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13046-019-1139-6","article-title":"Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib218","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-017-0528-y","article-title":"Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells","volume":"36","author":"Zheng","year":"2017","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101474_bib219","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jare.2024.06.014","article-title":"Tumor microenvironment as niche constructed by cancer stem cells: breaking the ecosystem to combat cancer","volume":"71","author":"Zhong","year":"2025","journal-title":"J. Adv. Res."},{"issue":"11","key":"10.1016\/j.drup.2026.101474_bib220","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s11864-022-01006-7","article-title":"BRAF inhibitor resistance in melanoma: mechanisms and alternative therapeutic strategies","volume":"23","author":"Zhong","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"issue":"8","key":"10.1016\/j.drup.2026.101474_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110462","article-title":"SHP2 mutations promote glycolysis and inhibit apoptosis via PKM2\/hnRNPK signaling in colorectal cancer","volume":"27","author":"Zhou","year":"2024","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.drup.2026.101474_bib222","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1158\/0008-5472.CAN-20-3665","article-title":"Spatiotemporal heterogeneity across metastases and organ-specific response informs drug efficacy and patient survival in colorectal cancer","volume":"81","author":"Zhou","year":"2021","journal-title":"Cancer Res."},{"issue":"54","key":"10.1016\/j.drup.2026.101474_bib223","doi-asserted-by":"crossref","first-page":"91990","DOI":"10.18632\/oncotarget.21121","article-title":"LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.drup.2026.101474_bib224","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-019-1095-1","article-title":"Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype","volume":"38","author":"Zhu","year":"2019","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.drup.2026.101474_bib225","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes. & Dis."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:48:01Z","timestamp":1790164081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626001263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":225,"alternative-id":["S1368764626001263"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101474","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicle-mediated drug resistance in cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101474"}}